IMSC Senior Manager, Project Systems & Reporting at Johnson & Johnson

Zug, Zug, Switzerland

Johnson & Johnson Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Pharmaceuticals, MedTechIndustries

Requirements

  • Expertise in project systems and reporting tools (e.g., Quickbase, Planisware, MS Project+)
  • Strong leadership and ability to provide guidance and oversight for global portfolio, programs, and projects
  • Experience in establishing systems, reporting, and analytics strategy
  • Knowledge of process ownership, lifecycle management, and integration with IT/JJSC
  • Capability to represent IMSC on cross-enterprise teams and manage vendors
  • Skills in delivering system expertise to achieve business objectives
  • Ability to work in a hybrid position at IMSC hub locations (e.g., Switzerland, USA, Ireland, etc.)

Responsibilities

  • Lead process and lifecycle ownership to deploy, document, and maintain systems and reporting, ensuring lean and effective designs integrated with IMSC strategy and execution
  • Own the execution of a technical strategic roadmap and system management, including reporting, application support, and collaboration with IT/JJSC
  • Partner with process integration requirements to deliver one end-to-end process including tools and performance reporting
  • Represent IMSC needs on cross-enterprise systems teams and lead IMSC vendor management for project tools (Quickbase, Planisware, MS Project+, etc.)
  • Deliver system expertise needed to achieve business objectives
  • Ensure day-to-day system support to the portfolio, program, and project management community and apply innovative solutions to optimize current systems and reporting
  • Develop and deliver the Strategic Roadmap for Portfolio, Program, and Project Systems & Reporting Tools
  • Identify the need for and lead the execution of system-related initiatives

Skills

Project Management
Systems Management
Reporting
Supply Chain Management
Program Management

Johnson & Johnson

Healthcare products in pharmaceuticals and devices.

About Johnson & Johnson

Johnson & Johnson operates in the healthcare sector with three main areas: pharmaceuticals, medical devices, and consumer health products. In the pharmaceuticals segment, the company develops prescription drugs for various medical conditions such as cancer and infectious diseases. The medical devices segment provides products used in surgeries and other medical procedures, while the consumer health segment offers over-the-counter products, including baby care and personal health items. Johnson & Johnson generates revenue through direct sales and partnerships, and it invests significantly in research and development to create new products that meet the needs of consumers and healthcare providers. The company stands out from competitors by emphasizing diversity, equity, and inclusion in its workplace, fostering an environment where employees can share their perspectives. Its goal is to improve patient outcomes and enhance the overall health and well-being of individuals globally.

New Brunswick, New JerseyHeadquarters
1886Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Risks

J&J faces a class action lawsuit in Australia over ineffective cold and flu medications.
Former J&J executives joining other firms could lead to increased competition.
Ongoing legal battles, like the lawsuit against Cigna, pose financial liabilities for J&J.

Differentiation

J&J operates in three segments: pharmaceuticals, medical devices, and consumer health.
The company invests heavily in R&D for innovative medical solutions and products.
J&J is committed to diversity, equity, and inclusion in its workplace culture.

Upsides

J&J's collaboration with Helsinki University Hospital focuses on value-based healthcare models.
The rise of personalized medicine offers J&J opportunities in targeted therapies.
Increased focus on digital health solutions presents expansion opportunities for J&J.

Land your dream remote job 3x faster with AI